Literature DB >> 11334561

Synthesis of 2beta-acyl-3beta-(substituted naphthyl)-8-azabicyclo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites.

H M Davies1, V Gilliatt, L A Kuhn, E Saikali, P Ren, P S Hammond, T Sexton, S R Childers.   

Abstract

A series of 3beta-naphthyltropane derivatives were synthesized and found to show high affinity at both the dopamine and serotonin transporter sites, leading to some of the most potent inhibitors known based on the tropane structure. Comparative molecular field analysis (CoMFA) models were developed for both dopamine and serotonin transporter binding data. These models provide insights into those factors that influence binding at the two transporters.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334561     DOI: 10.1021/jm000363+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Synthesis and structure-activity relationship studies of 3-biaryl-8-oxabicyclo[3.2.1]octane-2-carboxylic acid methyl esters.

Authors:  Lokman Torun; Bertha K Madras; Peter C Meltzer
Journal:  Bioorg Med Chem       Date:  2012-02-08       Impact factor: 3.641

2.  Singular value decomposition analysis of the torsional angles of dopamine reuptake inhibitor GBR 12909 analogs: effect of force field and charges.

Authors:  Deepangi Pandit; Anna Fiorentino; Supreet Bindra; Carol A Venanzi
Journal:  J Mol Model       Date:  2010-09-14       Impact factor: 1.810

3.  Hierarchical clustering analysis of flexible GBR 12909 dialkyl piperazine and piperidine analogs.

Authors:  Kathleen M Gilbert; Carol A Venanzi
Journal:  J Comput Aided Mol Des       Date:  2006-07-20       Impact factor: 3.686

4.  Conformational analysis of methylphenidate: comparison of molecular orbital and molecular mechanics methods.

Authors:  Kathleen M Gilbert; William J Skawinski; Milind Misra; Kristina A Paris; Neelam H Naik; Ronald A Buono; Howard M Deutsch; Carol A Venanzi
Journal:  J Comput Aided Mol Des       Date:  2004-11       Impact factor: 3.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.